. Author manuscript; available in PMC: 2022 Feb 8.

Published in final edited form as: J Am Acad Dermatol. 2019 Dec 17;82(6):1435–1444. doi: 10.1016/j.jaad.2019.12.020

Table 4.

Suggested Treatment Recommendations for Cases Interpreted as Conventional Spitz or Atypical Spitz by Pathologists’ Characteristics.

		Conventional Spitz					Atypical Spitz

	No. case readings	None	≤ .5	.5–1	≥ 1	P-value	None	≤ .5	.5–1	≥ 1	P-value
	No. case readings	34	39	4	1	P-value	8	90	71	25	P-value

Affiliation with academic medical center
No	6432	23 (43%)	28 (53%)	2 (4%)	0 (0%)	0.35	3 (2%)	65 (45%)	59 (40%)	19 (13%)	0.04
Yes	2544	11 (44%)	11 (44%)	2 (8%)	1 (4%)		5 (10%)	25 (52%)	12 (25%)	6 (13%)
Fellowship or board certified in dermatopathology
No	5424	19 (42%)	22 (49%)	3 (7%)	1 (2%)	0.89	4 (4%)	47 (46%)	38 (37%)	14 (14%)	0.98
Yes	3552	15 (45%)	17 (52%)	1 (3%)	0 (0%)		4 (4%)	43 (47%)	33 (36%)	11 (12%)
Years interpreting melanocytic skin lesions
< 10 Years	3552	8 (31%)	17 (65%)	1 (4%)	0 (0%)	0.24	2 (2%)	41 (48%)	32 (37%)	11 (13%)	0.78
10 years +	5424	26 (50%)	22 (42%)	3 (6%)	1 (2%)		6 (6%)	49 (45%)	39 (36%)	14 (13%)
Percent of caseload is melanocytic skin lesions
< 10 percent	3792	18 (50%)	15 (42%)	2 (6%)	1 (3%)	0.34	2 (3%)	32 (45%)	27 (38%)	10 (14%)	0.9
≥ 10 percent	5184	16 (38%)	24 (57%)	2 (5%)	0 (0%)		6 (5%)	58 (47%)	44 (36%)	15 (12%)